Abbas Khan

ORCID: 0000-0002-4288-7602
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Computational Drug Discovery Methods
  • vaccines and immunoinformatics approaches
  • SARS-CoV-2 and COVID-19 Research
  • Monoclonal and Polyclonal Antibodies Research
  • Bacteriophages and microbial interactions
  • Protein Structure and Dynamics
  • Viral Infections and Outbreaks Research
  • Bioinformatics and Genomic Networks
  • Immunotherapy and Immune Responses
  • Viral Infections and Vectors
  • RNA and protein synthesis mechanisms
  • Hepatitis B Virus Studies
  • Cancer therapeutics and mechanisms
  • Poxvirus research and outbreaks
  • Viral gastroenteritis research and epidemiology
  • Plant Virus Research Studies
  • COVID-19 Clinical Research Studies
  • Virology and Viral Diseases
  • Traditional and Medicinal Uses of Annonaceae
  • Birth, Development, and Health
  • RNA modifications and cancer
  • Protein Degradation and Inhibitors
  • Heavy Metal Exposure and Toxicity
  • Transgenic Plants and Applications
  • Glycosylation and Glycoproteins Research

Sunway University
2023-2025

Qatar University
2024-2025

Shanghai Jiao Tong University
2017-2024

Abdul Wali Khan University Mardan
2024

Dhaka Medical College and Hospital
2024

State Key Laboratory of Microbial Metabolism
2019-2023

Renewable Energy Systems (United States)
2023

Advantech AMT (Canada)
2023

Alpha and Omega Semiconductor (Bermuda)
2023

Robert Bosch (India)
2023

Sever acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a single-stranded RNA (ssRNA) virus, responsible for severe disease (COVID-19). A large number of natural compounds are under trial screening compounds, possessing potential inhibitory effect against the viral infection. Keeping in view importance marine antiviral activity, we investigated potency some products to target SARS-CoV-2 main protease (Mpro) (PDB ID 6MO3). The crystallographic structure Mpro an apo form was retrieved...

10.1080/07391102.2020.1769733 article EN Journal of Biomolecular Structure and Dynamics 2020-05-15

Pathologic hyperreactive inflammatory responses occur when there is excessive activation of a proinflammatory NF-κB pathway and reduced cytoprotective NRF2 cascade. The noncytotoxic, highly selective COX-2 inhibitory flavonol-enriched butanol fraction (UaB) from Uvaria alba (U. alba) was investigated for its modulating potential by targeting activity. Enzyme-linked immunosorbent assay initially performed to measure levels mediators [nitric oxide (NO), prostaglandin E2, reactive oxygen...

10.1021/acsomega.2c06451 article EN cc-by-nc-nd ACS Omega 2023-01-31

The novel coronavirus SARS-CoV2, the causative agent of pandemic disease COVID-19, emerged in December 2019 forcing lockdown communities many countries. absence specific drugs and vaccines, rapid transmission virus, increasing number deaths worldwide necessitated discovery new substances for anti-COVID-19 drug development. With aid bioinformatics computational modelling, ninety seven antiviral secondary metabolites from fungi were docked onto five SARS-CoV2 enzymes involved viral attachment,...

10.1080/07391102.2020.1776639 article EN Journal of Biomolecular Structure and Dynamics 2020-06-01

The emergence of recent SARS-CoV-2 has become a global health issue. This single-stranded positive-sense RNA virus is continuously spreading with increasing morbidities and mortalities. proteome this contains four structural sixteen nonstructural proteins that ensure the replication in host cell. However, role phosphoprotein (N) recognition, replicating, transcribing viral genome, modulating immune response indispensable. Recently, NMR structure N-terminal domain Nucleocapsid Phosphoprotein...

10.1016/j.csbj.2020.08.006 article EN cc-by Computational and Structural Biotechnology Journal 2020-01-01

The evolution of new SARS-CoV-2 variants around the globe has made COVID-19 pandemic more worrisome, further pressuring health care system and immunity. Novel variations that are unique to receptor-binding motif (RBM) domain (RBD) spike glycoprotein, i. e. L452R-E484Q, may play a different role in B.1.617 (also known as G/452R.V3) variant's pathogenicity better survival compared wild type. Therefore, thorough analysis is needed understand impact these mutations on binding with host receptor...

10.1002/cbic.202100191 article EN ChemBioChem 2021-06-23

Introduction: Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, has had a disastrous effect worldwide during the previous three years due to widespread infections with SARS-CoV-2 and its emerging variations. More than 674 million confirmed cases over 6.7 deaths have been attributed successive waves of as 29th January 2023. Similar other RNA viruses, is more susceptible genetic evolution spontaneous mutations time, resulting in continual emergence variants distinct characteristics....

10.3389/fphar.2023.1090717 article EN cc-by Frontiers in Pharmacology 2023-02-07

Abstract The outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome 2 (SARS-CoV-2) is spreading fast worldwide. There a pressing need to understand how the virus counteracts host innate immune responses. Deleterious clinical manifestations coronaviruses have been associated with virus-induced direct dysregulation responses occurring via viral macrodomains located within nonstructural protein-3 (Nsp3). However, no substantial information available...

10.1038/s41435-020-00120-6 article EN cc-by Genes and Immunity 2020-12-01

Inhibition of the major cyclic adenosine monophosphate-metabolizing enzyme PDE4 has shown potential for discovery drugs cancer, inflammation, and neurodegenerative disorders such as Alzheimer's disease. As a springboard to explore new anti-cancer anti-Alzheimer's chemical prototypes from rare Annonaceae species, present study evaluated anti-PDE4B along with antiproliferative anti-cholinesterase activities extracts Philippine endemic species Uvaria alba using in vitro assays framed resulting...

10.1021/acsomega.1c00137 article EN cc-by-nc-nd ACS Omega 2021-03-16

Cyclin-dependent kinase 2 (CDK2) is a promising target for cancer treatment, developing new effective CDK2 inhibitors of great significance in anticancer therapy. The involvement tumorigenesis has been debated, but recent evidence suggests that specifically inhibiting could be beneficial treating certain tumors. This approach remains attractive the development drugs. Several small-molecule targeting have reached clinical trials, selective inhibitor yet to discovered. In this study, we...

10.3390/biomedicines11082251 article EN cc-by Biomedicines 2023-08-11

In the current study, Neosetophomone B (NSP–B) was investigated for its anti-cancerous potential using network pharmacology, quantum polarized ligand docking, molecular simulation, and binding free energy calculation. Using SwissTarget prediction, Superpred, targets NSP-B were predicted while cancer-associated genes obtained from DisGeNet. Among total proteins, only 25 reported to overlap with disease-associated genes. A protein-protein interaction constructed by Cytoscape STRING databases....

10.3389/fphar.2024.1352907 article EN cc-by Frontiers in Pharmacology 2024-02-15
Coming Soon ...